These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23905706)

  • 21. [IVF in Sweden--continuous follow-up of children and mothers].
    Finnström O; Nygren NG; Olausson PO
    Lakartidningen; 2006 Aug 9-22; 103(32-33):2301-5. PubMed ID: 16955577
    [No Abstract]   [Full Text] [Related]  

  • 22. Ethics and reproductive medicine. Preface.
    Sauer MV
    Semin Reprod Med; 2010 Jul; 28(4):277-80. PubMed ID: 20694947
    [No Abstract]   [Full Text] [Related]  

  • 23. [A 10-year survey on birth defects after in vitro fertilization-embryo transfer in Shanghai].
    Han JL; Chen H; Niu ZH; Sun YJ; Sun XX; Zhao XM; Kuang YP; Teng XM; Ji YZ; Wang YB; Feng Y
    Zhonghua Fu Chan Ke Za Zhi; 2010 Feb; 45(2):124-7. PubMed ID: 20420783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Delivery of a healthy child from pregnancy after IVF complicated hyperstimulation syndrome, phlebothrombosis and resection of uterine horn. Case report].
    Jirsová S; Drbohlav P; Hájek Z; Brejchová M; Pasková A; Bláhová K; Rezábek K
    Ceska Gynekol; 2005 Mar; 70(2):149-52. PubMed ID: 15918271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safer embryo tests could boost IVF pregnancy rates.
    Pearson H
    Nature; 2006 Nov; 444(7115):12-3. PubMed ID: 17080048
    [No Abstract]   [Full Text] [Related]  

  • 26. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
    Fauser BC; Devroey P
    Fertil Steril; 2005 Jun; 83(6):1607-11. PubMed ID: 15950626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.
    Hernández ER; Gómez-Palomares JL; Ricciarelli E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1358-61. PubMed ID: 18555236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome.
    Várnagy A; Bódis J; Mánfai Z; Wilhelm F; Busznyák C; Koppán M
    Fertil Steril; 2010 May; 93(7):2281-4. PubMed ID: 19261278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of lead follicle diameter to initiate gonadotropin-releasing hormone antagonist does not affect in vitro fertilization clinical pregnancy, implantation, or live birth rates: a prospective, randomized study.
    Dayal MB; Frankfurter D; O'Hern C; Peak D; Dubey A; Gindoff PR
    Fertil Steril; 2009 Dec; 92(6):2047-9. PubMed ID: 19591990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The most extensive study of artificial insemination. Abnormalities are mostly common among children born after IVF].
    Orn P
    Lakartidningen; 1998 Sep; 95(36):3748-9. PubMed ID: 9766129
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-dose aspirin for prophylaxis of ovarian hyperstimulation syndrome.
    Várnagy A; Koppan M; Manfai Z; Busznyak C; Bodis J
    Fertil Steril; 2008 Apr; 89(4):1035-6. PubMed ID: 18353319
    [No Abstract]   [Full Text] [Related]  

  • 33. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr.
    Arslan M; Bocca S; Mirkin S; Barroso G; Stadtmauer L; Oehninger S
    Fertil Steril; 2005 Sep; 84(3):555-69. PubMed ID: 16169382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poor response--the devil is in the definition.
    Turhan NO
    Fertil Steril; 2006 Sep; 86(3):777; author reply 777. PubMed ID: 16952530
    [No Abstract]   [Full Text] [Related]  

  • 35. Ovarian hyperstimulation syndrome: an important complication of in vitro fertilization.
    Justice HM; Counselman FL
    Am J Emerg Med; 2008 Jan; 26(1):115.e3-4. PubMed ID: 18082809
    [No Abstract]   [Full Text] [Related]  

  • 36. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual renin-angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome.
    Ata B; Yakin K; Alatas C; Urman B
    Fertil Steril; 2008 Sep; 90(3):531-6. PubMed ID: 18001715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report.
    Rao AK; Chitkara U; Milki AA
    Hum Reprod; 2005 Dec; 20(12):3307-12. PubMed ID: 16085662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unpredictable cases of complicated ovarian hyperstimulation in IVF.
    Delvigne A; Vandromme J; Demeestere I; Leroy F
    Int J Fertil Womens Med; 1997; 42(4):268-70. PubMed ID: 9309462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two cases of cholestasis in the first trimester of pregnancy after ovarian hyperstimulation.
    Zamah AM; El-Sayed YY; Milki AA
    Fertil Steril; 2008 Oct; 90(4):1202.e7-10. PubMed ID: 18929050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.